TRANS-2-(PYRIDIN-4-YL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 200mg

3,4-Dibromo-2-pyridinamine, 1g

tert-Butyl 3-(2,4-difluorophenyl)-3-hydroxyazetidine-1-carboxylate, 98%, 250mg

MAPCHO-10, 95.0%, 5g

3-(2-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)ETHOXY)PROPANOIC ACID, 95%, 250mg

3-((4-(Methyl(4-(3-(4-(trifluoromethoxy)phenyl)ureido)phenyl)amino)pyrimidin-2-yl)amino)benzenesulfonamide, 98+%, 250mg

4-Bromo-4'-phenyltriphenylamine>98.0%(GC)1g

(R)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol, 95.0%, 1g

3-(5'-Indole)phenyl acetic acid, 97.0%, 250mg

VIPADENANT, 95%, 25mg

4-(Phenoxymethyl)piperidine hydrochloride, 95%, 2.5g

5-Bromo-2-(4-methylpiperazin-1-yl)pyrimidine, 95.0%, 1g

6-Amino-3-methyl-5-nitrosopyrimidine-2,4(1H,3H)-dione, 98+%, 5g